chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Vaccination complication
Clinical narrative: Pain in lower pelvis pain and crotch pain area worsened; Non-specific report of reaction to vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain in lower pelvis pain and crotch pain area worsened) and VACCINATION COMPLICATION (Non-specific report of reaction to vaccine) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     Concurrent medical conditions included Pelvic pain (Experiencing lower pelvic pain and crotch pain.) and Gallstones. Concomitant products included ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL (EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;PARACETAMOL]), MULTIVITAMIN [VITAMINS NOS], CALCIUM and NAPROXEN for an unknown indication.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced PAIN (Pain in lower pelvis pain and crotch pain area worsened) and VACCINATION COMPLICATION (Non-specific report of reaction to vaccine). At the time of the report, PAIN (Pain in lower pelvis pain and crotch pain area worsened) and VACCINATION COMPLICATION (Non-specific report of reaction to vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021:
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Tested positive for covid after receiving the first dose of the vaccine; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of SARS-COV-2 TEST POSITIVE (Tested positive for covid after receiving the first dose of the vaccine) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 immunisation.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for covid after receiving the first dose of the vaccine). At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive for covid after receiving the first dose of the vaccine) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-016742 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Injection site pain
Clinical narrative: pain in her arm; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 03-Feb-2021 and was forwarded to Moderna on 03-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (pain in her arm) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse reaction (No medical history reported.). Concomitant products included BISOPROLOL FUMARATE (ZEBETA) for an unknown indication.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced INJECTION SITE PAIN (pain in her arm). On 14-Jan-2021, INJECTION SITE PAIN (pain in her arm) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Jan-2021, COVID-19: positive positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Burning sensation, Paraesthesia, Pruritus, Rash macular
Clinical narrative: 2 blotches 1.5 inches and a dime size; Tender to touch; Itching sensation; Burning sensation; paresthesia in both the hand and wrist in the opposing hand from injectionP; Arthritic pain awaken; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 31-Jan-2021 and was forwarded to Moderna on 01-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (2 blotches 1.5 inches and a dime size), TENDERNESS (Tender to touch), PRURITUS (Itching sensation), BURNING SENSATION (Burning sensation) and PARAESTHESIA (paresthesia in both the hand and wrist in the opposing hand from injectionP) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 27-Jan-2021, the patient experienced RASH MACULAR (2 blotches 1.5 inches and a dime size), TENDERNESS (Tender to touch), PRURITUS (Itching sensation), BURNING SENSATION (Burning sensation), PARAESTHESIA (paresthesia in both the hand and wrist in the opposing hand from injectionP) and ARTHRALGIA (Arthritic pain awaken). At the time of the report, RASH MACULAR (2 blotches 1.5 inches and a dime size), TENDERNESS (Tender to touch), PRURITUS (Itching sensation), BURNING SENSATION (Burning sensation), PARAESTHESIA (paresthesia in both the hand and wrist in the opposing hand from injectionP) and ARTHRALGIA (Arthritic pain awaken) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided. Concomitant medication was not provided.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Tenderness
Clinical narrative: 2 blotches 1.5 inches and a dime size; Tender to touch; Itching sensation; Burning sensation; paresthesia in both the hand and wrist in the opposing hand from injectionP; Arthritic pain awaken; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 31-Jan-2021 and was forwarded to Moderna on 01-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (2 blotches 1.5 inches and a dime size), TENDERNESS (Tender to touch), PRURITUS (Itching sensation), BURNING SENSATION (Burning sensation) and PARAESTHESIA (paresthesia in both the hand and wrist in the opposing hand from injectionP) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 27-Jan-2021, the patient experienced RASH MACULAR (2 blotches 1.5 inches and a dime size), TENDERNESS (Tender to touch), PRURITUS (Itching sensation), BURNING SENSATION (Burning sensation), PARAESTHESIA (paresthesia in both the hand and wrist in the opposing hand from injectionP) and ARTHRALGIA (Arthritic pain awaken). At the time of the report, RASH MACULAR (2 blotches 1.5 inches and a dime size), TENDERNESS (Tender to touch), PRURITUS (Itching sensation), BURNING SENSATION (Burning sensation), PARAESTHESIA (paresthesia in both the hand and wrist in the opposing hand from injectionP) and ARTHRALGIA (Arthritic pain awaken) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided. Concomitant medication was not provided.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Hypersomnia
Clinical narrative: fatigue; slowest down her brain again, hit her down/ it was not a dizziness, could hardly think; had to go to bed and could not get up that night; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FEELING ABNORMAL (slowest down her brain again, hit her down/ it was not a dizziness, could hardly think), HYPERSOMNIA (had to go to bed and could not get up that night) and FATIGUE (fatigue) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026LC0A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (had a very bad time, had to be hospitalized for 10 days because the virus affected her brain; she felt she could not think, or operate.) in July 2020. Concomitant products included PARACETAMOL (TYLENOL) for Arthritis, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) and LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced FEELING ABNORMAL (slowest down her brain again, hit her down/ it was not a dizziness, could hardly think) and HYPERSOMNIA (had to go to bed and could not get up that night). On 23-Jan-2021, the patient experienced FATIGUE (fatigue). On 23-Jan-2021, FEELING ABNORMAL (slowest down her brain again, hit her down/ it was not a dizziness, could hardly think) outcome was unknown. At the time of the report, HYPERSOMNIA (had to go to bed and could not get up that night) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications also included blood pressure medications and medication for bedtime. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Chills
Clinical narrative: 2-week delayed reaction of extreme chiills; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (2-week delayed reaction of extreme chiills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (2-week delayed reaction of extreme chiills). At the time of the report, CHILLS (2-week delayed reaction of extreme chiills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment and concomitant medications were not provided by reporter.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the event, a causal relationship cannot be excluded.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Arthralgia, Chills, Decreased appetite, Dizziness
Clinical narrative: This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of DIZZINESS (lightheaded), TREMOR (uncontrollable shakiness), DECREASED APPETITE (loss of appetite), ABDOMINAL PAIN UPPER (stomach ache) and ARTHRALGIA (Arthritic pain and her joints were painful) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 26-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, the patient experienced DIZZINESS (lightheaded), TREMOR (uncontrollable shakiness), DECREASED APPETITE (loss of appetite), CHILLS (Chills) and NAUSEA (Nauseated). On 29-Jan-2021, the patient experienced ABDOMINAL PAIN UPPER (stomach ache), ARTHRALGIA (Arthritic pain and her joints were painful) and FATIGUE (tired). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, DIZZINESS (lightheaded), TREMOR (uncontrollable shakiness), DECREASED APPETITE (loss of appetite), ABDOMINAL PAIN UPPER (stomach ache), ARTHRALGIA (Arthritic pain and her joints were painful), CHILLS (Chills), FATIGUE (tired) and NAUSEA (Nauseated) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment details included Ibuprofen. No relevant concomitant medications reported. Action taken with mRNA-1273 in response to the events was not applicable.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nausea, Tremor
Clinical narrative: This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of DIZZINESS (lightheaded), TREMOR (uncontrollable shakiness), DECREASED APPETITE (loss of appetite), ABDOMINAL PAIN UPPER (stomach ache) and ARTHRALGIA (Arthritic pain and her joints were painful) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 26-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, the patient experienced DIZZINESS (lightheaded), TREMOR (uncontrollable shakiness), DECREASED APPETITE (loss of appetite), CHILLS (Chills) and NAUSEA (Nauseated). On 29-Jan-2021, the patient experienced ABDOMINAL PAIN UPPER (stomach ache), ARTHRALGIA (Arthritic pain and her joints were painful) and FATIGUE (tired). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, DIZZINESS (lightheaded), TREMOR (uncontrollable shakiness), DECREASED APPETITE (loss of appetite), ABDOMINAL PAIN UPPER (stomach ache), ARTHRALGIA (Arthritic pain and her joints were painful), CHILLS (Chills), FATIGUE (tired) and NAUSEA (Nauseated) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment details included Ibuprofen. No relevant concomitant medications reported. Action taken with mRNA-1273 in response to the events was not applicable.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Erythema, Fatigue, Tremor
Clinical narrative: face turned really red; lightheadedness on rising; see stars on rising; I had severe tremors; fatigue; A spontaneous report was received from a nurse concerning a 58-year-old, female patient who experienced the events of my face turned really red, fatigue, tremor, and lightheadedness on rising, I see stars on rising.   The patient's medical history was not provided. Concomitant product use was not provided/unknown by the reporter.    On 28 Jan 2021, prior to the onset of the events, the patient received their second of two planned doses of mRNA-1273 (lot/batch: 043L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  Details of first dose of mRNA vaccine was not reported.  On 28 Jan 2021, the patient experienced the events erythema, fatigue, dizziness, and tremor.   The patient reported that her face and cheeks turned red, felt fatigue, felt lightheadedness on rising and had severe tremors in the night for 2 hours.  Action taken with mRNA-1273 in response to the events was not applicable.  The outcome of the events erythema, fatigue, dizziness, and tremor was resolved.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Pain in extremity, Pyrexia, Vaccination site swelling
Clinical narrative: Fever that went to 101F; Became tired; Shortness of breath; Pain from her head to her toes; Swelling below the injection site; A spontaneous report was received from a Healthcare Professional concerning a female  patient who received Moderna's COVID-19 vaccine (mRNA-1273).  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 25 Jan 2021, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot/batch: 013L20A) intramuscularly in the left deltoid for prophylaxis of COVID-19 infection.  On 25 Jan 2021, post vaccination over few days, she was tired, had fever that went up to 101 F and pain from her head to her toes, self treated with Tylenol and Motrin. She had an episode of shortness of breath and used two puffs of albuterol. She noticed swelling below the injection site around 10 cm x 5 cm. She reported no problems to her first shot.   Action taken with mRNA-1273 in response to the events is not applicable.  The outcome of events were not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: Painful lymph nodes; lymph nodes are enlarged/swollen lymph nodes; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of LYMPH NODE PAIN (Painful lymph nodes) and LYMPHADENOPATHY (lymph nodes are enlarged/swollen lymph nodes) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LYMPH NODE PAIN (Painful lymph nodes) and LYMPHADENOPATHY (lymph nodes are enlarged/swollen lymph nodes). At the time of the report, LYMPH NODE PAIN (Painful lymph nodes) and LYMPHADENOPATHY (lymph nodes are enlarged/swollen lymph nodes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient noticed swelling under his arm on the second week after receiving the vaccine. Patient stated he visited a health care provider for the events, who confirmed swollen lymph nodes. Patient was then prescribed Levocet (levocetirizine) for treatment of events.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Influenza like illness, Myalgia, Pain
Clinical narrative: flu-llike symptoms; chills are uncontrollable; body is so sore; chills; muscle pain; aches; headache; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 27-Jan-2021 and was forwarded to Moderna on 01-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), MYALGIA (muscle pain), PAIN (aches), HEADACHE (headache) and INFLUENZA LIKE ILLNESS (flu-llike symptoms) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event since an unknown date.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, the patient experienced CHILLS (chills), MYALGIA (muscle pain), PAIN (aches) and HEADACHE (headache). On 28-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu-llike symptoms), CHILLS (chills are uncontrollable) and PAIN (body is so sore). At the time of the report, CHILLS (chills), MYALGIA (muscle pain), PAIN (aches), HEADACHE (headache), INFLUENZA LIKE ILLNESS (flu-llike symptoms), CHILLS (chills are uncontrollable) and PAIN (body is so sore) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Treatment information was not provided. Concomitant medication was not provided.
Age: 96.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Sleep disorder due to general medical condition, insomnia type, Vaccination site pain, Vertigo
Clinical narrative: 30 min of vertigo episode; Couldn't barely get to bed without falling/Felt like something was pulling him backwards; Arm was a little sore; Didn't sleep relaxed; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (30 min of vertigo episode), ASTHENIA (Couldn't barely get to bed without falling/Felt like something was pulling him backwards), SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE (Didn't sleep relaxed) and VACCINATION SITE PAIN (Arm was a little sore) in a 96-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 011G28) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure. Concomitant products included BENAZEPRIL HYDROCHLORIDE, HYDROCHLOROTHIAZIDE (BENAZEPRIL/HCTZ) for Blood pressure abnormal, METOPROLOL for an unknown indication.   On 02-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Feb-2021, the patient experienced SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE (Didn't sleep relaxed). On 02-Feb-2021, the patient experienced VERTIGO (30 min of vertigo episode), ASTHENIA (Couldn't barely get to bed without falling/Felt like something was pulling him backwards) and VACCINATION SITE PAIN (Arm was a little sore). On 03-Feb-2021, VACCINATION SITE PAIN (Arm was a little sore) had resolved. At the time of the report, VERTIGO (30 min of vertigo episode), ASTHENIA (Couldn't barely get to bed without falling/Felt like something was pulling him backwards) and SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE (Didn't sleep relaxed) outcome was unknown.            No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: The patient height, weight, concomitant medication was provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Dry eye, Dry mouth, Headache, Lethargy
Clinical narrative: dry eyes; dry mouth; injection site is pink and hot; total lethargy; injection site is pink and hot; Headache; temperature of 101.5; This spontaneous case was reported by a consumer and describes the occurrence of DRY EYE (dry eyes), DRY MOUTH (dry mouth), VACCINATION SITE WARMTH (injection site is pink and hot), LETHARGY (total lethargy) and VACCINATION SITE ERYTHEMA (injection site is pink and hot) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LISINOPRIL and PRAVASTATIN for an unknown indication.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced DRY EYE (dry eyes), DRY MOUTH (dry mouth), VACCINATION SITE WARMTH (injection site is pink and hot), LETHARGY (total lethargy), VACCINATION SITE ERYTHEMA (injection site is pink and hot), HEADACHE (Headache) and PYREXIA (temperature of 101.5). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DRY EYE (dry eyes), DRY MOUTH (dry mouth), VACCINATION SITE WARMTH (injection site is pink and hot), LETHARGY (total lethargy), VACCINATION SITE ERYTHEMA (injection site is pink and hot) and HEADACHE (Headache) outcome was unknown and PYREXIA (temperature of 101.5) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Jan-2021, Body temperature: 101.5 temperature of 101.5.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment details included Tylenol, Ice pack.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site erythema, Vaccination site warmth
Clinical narrative: dry eyes; dry mouth; injection site is pink and hot; total lethargy; injection site is pink and hot; Headache; temperature of 101.5; This spontaneous case was reported by a consumer and describes the occurrence of DRY EYE (dry eyes), DRY MOUTH (dry mouth), VACCINATION SITE WARMTH (injection site is pink and hot), LETHARGY (total lethargy) and VACCINATION SITE ERYTHEMA (injection site is pink and hot) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LISINOPRIL and PRAVASTATIN for an unknown indication.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced DRY EYE (dry eyes), DRY MOUTH (dry mouth), VACCINATION SITE WARMTH (injection site is pink and hot), LETHARGY (total lethargy), VACCINATION SITE ERYTHEMA (injection site is pink and hot), HEADACHE (Headache) and PYREXIA (temperature of 101.5). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DRY EYE (dry eyes), DRY MOUTH (dry mouth), VACCINATION SITE WARMTH (injection site is pink and hot), LETHARGY (total lethargy), VACCINATION SITE ERYTHEMA (injection site is pink and hot) and HEADACHE (Headache) outcome was unknown and PYREXIA (temperature of 101.5) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Jan-2021, Body temperature: 101.5 temperature of 101.5.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment details included Tylenol, Ice pack.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Neck pain
Clinical narrative: Neck pain; Elbow pain,Shoulder pain; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Neck pain) and ARTHRALGIA (Elbow pain,Shoulder pain) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced NECK PAIN (Neck pain) and ARTHRALGIA (Elbow pain,Shoulder pain). At the time of the report, NECK PAIN (Neck pain) and ARTHRALGIA (Elbow pain,Shoulder pain) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitants or treatment medications were reported.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Nausea, Pain in extremity, Vomiting
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), VOMITING (vomiting), CHILLS (chills), NAUSEA (nausea) and HEADACHE (headache) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concomitant products included ATORVASTATIN CALCIUM (LIPITOR) and VITAMINS NOS (DAILY VITAMINS) for an unknown indication. On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm), VOMITING (vomiting), CHILLS (chills), NAUSEA (nausea) and HEADACHE (headache). At the time of the report, PAIN IN EXTREMITY (sore arm) had resolved and VOMITING (vomiting), CHILLS (chills), NAUSEA (nausea) and HEADACHE (headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Migraine, Pain, Panic attack, Vaccination site pain
Clinical narrative: Soreness; Migraine headaches; Dizziness; Panic attack; pain at the injection; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Soreness), MIGRAINE (Migraine headaches), DIZZINESS (Dizziness), PANIC ATTACK (Panic attack) and VACCINATION SITE PAIN (pain at the injection) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     The patient's past medical history included Panic attacks and Surgery (Minor surgery) on 18-Jan-2021. Concurrent medical conditions included Chronic migraine and Allergy (Allergic to nickel due to metal implant in heart).    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (Soreness), MIGRAINE (Migraine headaches), DIZZINESS (Dizziness), PANIC ATTACK (Panic attack) and VACCINATION SITE PAIN (pain at the injection). At the time of the report, PAIN (Soreness) and VACCINATION SITE PAIN (pain at the injection) had resolved and MIGRAINE (Migraine headaches), DIZZINESS (Dizziness) and PANIC ATTACK (Panic attack) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.    Most recent FOLLOW-UP information incorporated above includes: On 04-Feb-2021: No specific follow-up information recorded.
Sex: F
Vaccine: COVID19
Symptoms: Injection site reaction, Limb discomfort
Clinical narrative: covid arm; I had a tennis-ball-sized circle a few inches below the injection; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (covid arm) and INJECTION SITE REACTION (I had a tennis-ball-sized circle a few inches below the injection) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced LIMB DISCOMFORT (covid arm) and INJECTION SITE REACTION (I had a tennis-ball-sized circle a few inches below the injection). At the time of the report, LIMB DISCOMFORT (covid arm) and INJECTION SITE REACTION (I had a tennis-ball-sized circle a few inches below the injection) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pruritus, Rash erythematous
Clinical narrative: Stomach and Back has a red rash; It is itching; It is sore; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Stomach and Back has a red rash), PRURITUS (It is itching) and PAIN (It is sore) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, the patient experienced RASH ERYTHEMATOUS (Stomach and Back has a red rash), PRURITUS (It is itching) and PAIN (It is sore). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, RASH ERYTHEMATOUS (Stomach and Back has a red rash), PRURITUS (It is itching) and PAIN (It is sore) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Choking sensation, Dry throat, Nasal congestion, Pain in extremity
Clinical narrative: Sore arm; Stuffed-up nose, felt like it was full of cement; Throat was very dry; She felt like she was choking; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), NASAL CONGESTION (Stuffed-up nose, felt like it was full of cement), DRY THROAT (Throat was very dry) and CHOKING SENSATION (She felt like she was choking) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     The patient's past medical history included Seasonal allergy. Concomitant products included METOPROLOL, AMLODIPINE BESILATE (NORVASC) and B & FOLIC for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), NASAL CONGESTION (Stuffed-up nose, felt like it was full of cement), DRY THROAT (Throat was very dry) and CHOKING SENSATION (She felt like she was choking). At the time of the report, PAIN IN EXTREMITY (Sore arm), NASAL CONGESTION (Stuffed-up nose, felt like it was full of cement), DRY THROAT (Throat was very dry) and CHOKING SENSATION (She felt like she was choking) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.   No treatment information was provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Vaccination site erythema, Vaccination site swelling
Clinical narrative: Tingling down her arm, in her finger and palm; Swelling; Redness; This spontaneous case was reported by a health care professional and describes the occurrence of PARAESTHESIA (Tingling down her arm, in her finger and palm), VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE ERYTHEMA (Redness) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE ERYTHEMA (Redness). On 09-Jan-2021, the patient experienced PARAESTHESIA (Tingling down her arm, in her finger and palm). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event following immunisation, at an unspecified dose and frequency. On 23-Jan-2021, VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE ERYTHEMA (Redness) had resolved. At the time of the report, PARAESTHESIA (Tingling down her arm, in her finger and palm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: Epistaxis, Heart rate increased, Pain in extremity, Pyrexia
Clinical narrative: blood in nose; FEVER; arm hurt; Husband felt heart thump thump; This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (blood in nose), PYREXIA (FEVER), PAIN IN EXTREMITY (arm hurt) and HEART RATE INCREASED (Husband felt heart thump thump) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (hospitalized and got pneumonia ,had blood clot) in November 2020.    On 12-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 19-Jan-2021, the patient experienced EPISTAXIS (blood in nose), PYREXIA (FEVER), PAIN IN EXTREMITY (arm hurt) and HEART RATE INCREASED (Husband felt heart thump thump). The patient was treated with CALCIUM CARBONATE (ANTACID [CALCIUM CARBONATE]) at an unspecified dose and frequency. At the time of the report, EPISTAXIS (blood in nose), PYREXIA (FEVER) and PAIN IN EXTREMITY (arm hurt) outcome was unknown and HEART RATE INCREASED (Husband felt heart thump thump) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications was not reported . Patient took antacid and felt better.
Sex: F
Vaccine: COVID19
Symptoms: Adverse drug reaction
Clinical narrative: Reaction; A spontaneous report was received from a consumer concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced reaction.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: not reported) unknown route for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced a reaction.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was unknown.   The outcome of event(s), reaction, was unknown.; Reporter's Comments: Very limited information regarding this event has been provided at this time.  Further information has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Injection site pruritus, Vaccination site erythema, Vaccination site warmth
Clinical narrative: has a huge circle on her arm 3 1/2 inches; itching; worm; red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (worm), CONTUSION (has a huge circle on her arm 3 1/2 inches), VACCINATION SITE ERYTHEMA (red) and INJECTION SITE PRURITUS (itching) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced VACCINATION SITE WARMTH (worm) and VACCINATION SITE ERYTHEMA (red). On 31-Jan-2021, the patient experienced INJECTION SITE PRURITUS (itching). On an unknown date, the patient experienced CONTUSION (has a huge circle on her arm 3 1/2 inches). On 24-Jan-2021, VACCINATION SITE WARMTH (worm) had resolved. At the time of the report, CONTUSION (has a huge circle on her arm 3 1/2 inches) outcome was unknown and VACCINATION SITE ERYTHEMA (red) and INJECTION SITE PRURITUS (itching) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications was reported.  No treatment information was provided
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site rash, Vaccination site swelling
Clinical narrative: rash at the injection site; swelling; soreness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (rash at the injection site), VACCINATION SITE SWELLING (swelling) and VACCINATION SITE PAIN (soreness) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 030L20A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and SIMVASTATIN for an unknown indication.   On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 31-Jan-2021, the patient experienced VACCINATION SITE RASH (rash at the injection site), VACCINATION SITE SWELLING (swelling) and VACCINATION SITE PAIN (soreness). At the time of the report, VACCINATION SITE RASH (rash at the injection site), VACCINATION SITE SWELLING (swelling) and VACCINATION SITE PAIN (soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included Ice, Cortisone Cream
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Epistaxis, Pain in extremity, Palpitations, Pyrexia
Clinical narrative: A week later both had some blood in nose, fever, and arm hurt; A week later both had some blood in nose, fever, and arm hurt; A week later both had some blood in nose, fever, and arm hurt; Husband felt heart thump thump-took antacid felt better; This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (A week later both had some blood in nose, fever, and arm hurt), PAIN IN EXTREMITY (A week later both had some blood in nose, fever, and arm hurt), PYREXIA (A week later both had some blood in nose, fever, and arm hurt) and PALPITATIONS (Husband felt heart thump thump-took antacid felt better) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 and Pneumonia.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced EPISTAXIS (A week later both had some blood in nose, fever, and arm hurt), PAIN IN EXTREMITY (A week later both had some blood in nose, fever, and arm hurt), PYREXIA (A week later both had some blood in nose, fever, and arm hurt) and PALPITATIONS (Husband felt heart thump thump-took antacid felt better). The patient was treated with CALCIUM CARBONATE (ANTACID [CALCIUM CARBONATE]) at a dose of UNK dosage form. At the time of the report, EPISTAXIS (A week later both had some blood in nose, fever, and arm hurt), PAIN IN EXTREMITY (A week later both had some blood in nose, fever, and arm hurt) and PYREXIA (A week later both had some blood in nose, fever, and arm hurt) outcome was unknown and PALPITATIONS (Husband felt heart thump thump-took antacid felt better) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. Had Covid-19 in November-was hospitalized- got pneumonia, had a blood clot.  .
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site swelling, Vaccination site warmth
Clinical narrative: warm; Swollen on the injection site (left arm); red (on the injection site); aching (on the injection site); This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (warm), VACCINATION SITE SWELLING (Swollen on the injection site (left arm)), VACCINATION SITE ERYTHEMA (red (on the injection site)) and VACCINATION SITE PAIN (aching (on the injection site)) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0113J0A) for COVID-19 vaccination.     Concurrent medical conditions included AFib. Concomitant products included APIXABAN (ELIQUIS) for Atrial fibrillation.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced VACCINATION SITE WARMTH (warm), VACCINATION SITE SWELLING (Swollen on the injection site (left arm)), VACCINATION SITE ERYTHEMA (red (on the injection site)) and VACCINATION SITE PAIN (aching (on the injection site)). The patient was treated with KETOROLAC TROMETHAMINE (TORADOL) for Pain, at a dose of 1 dosage form. At the time of the report, VACCINATION SITE WARMTH (warm), VACCINATION SITE SWELLING (Swollen on the injection site (left arm)), VACCINATION SITE ERYTHEMA (red (on the injection site)) and VACCINATION SITE PAIN (aching (on the injection site)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient was schedule 2nd dose on February 4 Treatment medication information included Antibiotics   Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2021: TCR received contains No new Information; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling jittery, Injection site pain, Injection site warmth, Nausea
Clinical narrative: on/ off Jitteriness; injection site was hot; Injection site was sore, painful, tender; Fatigue; nausea but no vomiting; This spontaneous case was reported by a consumer and describes the occurrence of FEELING JITTERY (on/ off Jitteriness), INJECTION SITE WARMTH (injection site was hot), INJECTION SITE PAIN (Injection site was sore, painful, tender), FATIGUE (Fatigue) and NAUSEA (nausea but no vomiting) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced FEELING JITTERY (on/ off Jitteriness), INJECTION SITE WARMTH (injection site was hot), INJECTION SITE PAIN (Injection site was sore, painful, tender), FATIGUE (Fatigue) and NAUSEA (nausea but no vomiting). At the time of the report, FEELING JITTERY (on/ off Jitteriness), INJECTION SITE WARMTH (injection site was hot), INJECTION SITE PAIN (Injection site was sore, painful, tender), FATIGUE (Fatigue) and NAUSEA (nausea but no vomiting) outcome was unknown.            No concomitant medications were provided.  No treatment medication was provided.
Sex: F
Vaccine: COVID19
Symptoms: Adverse event following immunisation
Clinical narrative: strange side effect after her second dose; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT FOLLOWING IMMUNISATION (strange side effect after her second dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT FOLLOWING IMMUNISATION (strange side effect after her second dose). At the time of the report, ADVERSE EVENT FOLLOWING IMMUNISATION (strange side effect after her second dose) outcome was unknown.            No concomitants or treatment medications were reported.